165 Followers on Owler

InSymbiosis

Read more
CEO Avatar

President & CEO

Dean Wenham

CEO Approval Rating

90/100

Founded

2005

Headquarters

Update Address

Status

PrivateSubsidiary of Camargo Pharmaceutical Services

Est. Annual Revenue
$7.6M
Agree?
Est. Employees
21
Agree?
Funding
$0
Industry

Update Industry
Sector

Update Industry

InSymbiosis Competitors and Alternatives

1
3
5
7
9
2
4
6
8
10
See more competitor data

InSymbiosis News

InSymbiosis Headquarters

InSymbiosis Summary

ABOUT

Overview

InSymbiosis is a contract research organization that provides drug development services to pharmaceutical and biotechnology companies. InSymbiosis was founded in 2005. InSymbiosis' President & CEO, Dean Wenham, currently has an approval rating of 90%...

CEO

InSymbiosis's President & CEO, Dean Wenham, currently has an approval rating of 90%. InSymbiosis's primary competitors are Novum Pharmaceutical Research Services, Inc., Everest & BioPharma Services.

Acquisitions

There have been no acquisitions found related to InSymbiosis

Funding

Funding data cannot be found related to InSymbiosis

Investments

Recent investment data cannot be found related to InSymbiosis

Frequently Asked Questions about InSymbiosis

  1. When was InSymbiosis founded?

    InSymbiosis was founded in 2005
  2. Who is InSymbiosis's CEO?

    InSymbiosis's CEO is Dean Wenham
  3. How much revenue does InSymbiosis generate?

    InSymbiosis generates $7.6M in revenue
  1. How much funding does InSymbiosis have?

    InSymbiosis has historically raised $0 in funding
  2. How many employees does InSymbiosis have?

    InSymbiosis has 21 employees
  3. Who are InSymbiosis's competitors?

    InSymbiosis's top competitors are Novum Pharmaceutical Research Services, Inc., Everest, BioPharma Services

Trending Companies